CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease Nitrosative stress drives heart failure with preserved ejection fraction Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction Ambulatory Inotrope Infusions in Advanced Heart Failure - A Systematic Review and Meta-Analysis The year in cardiovascular medicine 2020: heart failure and cardiomyopathies SPECT and PET in ischemic heart failure Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF Risk of Mortality Following Catheter Ablation of Atrial Fibrillation Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)

Original Research2021 Jan 12;S0828-282X(21)00005-2.

JOURNAL:Can J Cardiol. Article Link

When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease

E O'Meara, S Verma. Keywords: SGLT2 inhibitors; heart failure; chronic kidney disease

Full Text PDF